This afternoon we watched Teva Pharmaceutical Industries rise 1.9% to a price of $19.31 per share. The Large-Cap Pharmaceutical company is now trading -18.03% below its average target price of $23.56. Analysts have set target prices ranging from $18.0 to $29.0 per share for Teva Pharmaceutical Industries, and have given the stock an average rating of buy.
Teva Pharmaceutical Industries's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4.0%. The stock's short ratio is 3.73. At 0.0%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.
Another number to watch is the company's rate of institutional share ownership, which now stands at 65.1%. In conclusion, we believe there is mixed market sentiment regarding Teva Pharmaceutical Industries.
Institutions Invested in Teva Pharmaceutical Industries
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | FMR, LLC | 5% | 58,135,616 | $1,122,517,324 |
| 2025-06-30 | Blackrock Inc. | 5% | 54,318,382 | $1,048,811,882 |
| 2025-06-30 | Menora Mivtachim Holdings Ltd. | 3% | 38,493,294 | $743,251,596 |
| 2025-06-30 | Phoenix Financial Ltd. | 3% | 37,761,444 | $729,120,597 |
| 2025-06-30 | Harel Insurance Investments & Financial Services Ltd. | 3% | 33,390,327 | $644,720,450 |
| 2025-06-30 | Clal Insurance Enterprises Holdings Ltd | 3% | 32,362,683 | $624,878,083 |
| 2025-06-30 | Migdal Insurance & Financial Holdings Ltd. | 2% | 28,685,422 | $553,875,324 |
| 2025-06-30 | Lingotto Investment Management LLP | 2% | 28,156,918 | $543,670,652 |
| 2025-06-30 | Rubric Capital Management LP | 2% | 26,000,000 | $502,023,586 |
| 2025-06-30 | PointState Capital LP | 2% | 20,712,398 | $399,927,397 |
